Stock Track | Elanco Animal Health Soars 9.25% Pre-Market on Strong Q2 Results and Raised 2025 Outlook

Stock Track

Aug 07

Shares of Elanco Animal Health Inc (ELAN) surged 9.25% in pre-market trading on Thursday following the release of the company's impressive second-quarter results and an upward revision of its full-year 2025 guidance.

Elanco reported Q2 adjusted earnings of $0.26 per share, surpassing analysts' expectations of $0.20. While this represents a decrease from $0.30 in the same period last year, it demonstrates the company's resilience in a challenging market. Revenue for the quarter ended June 30 reached $1.24 billion, up from $1.18 billion a year earlier and exceeding the FactSet consensus estimate of $1.19 billion.

The animal health company has raised its full-year 2025 outlook, now projecting adjusted earnings per share between $0.85 and $0.91, up from the previous forecast of $0.80 to $0.86. Revenue guidance for 2025 has also been increased to a range of $4.57 billion to $4.62 billion, compared to the earlier projection of $4.51 billion to $4.58 billion. This optimistic outlook, coupled with the strong Q2 performance, has fueled investor enthusiasm, driving the significant pre-market rally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1135454044"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135454044\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135454044?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-07 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135454044","market":"us","top_or_hot":-1,"title":"Stock Track | Elanco Animal Health Soars 9.25% Pre-Market on Strong Q2 Results and Raised 2025 Outlook","media":"Stock Track","content":"<p>Shares of Elanco Animal Health Inc (ELAN) surged 9.25% in pre-market trading on Thursday following the release of the company's impressive second-quarter results and an upward revision of its full-year 2025 guidance.</p>\n\n<p>Elanco reported Q2 adjusted earnings of $0.26 per share, surpassing analysts' expectations of $0.20. While this represents a decrease from $0.30 in the same period last year, it demonstrates the company's resilience in a challenging market. Revenue for the quarter ended June 30 reached $1.24 billion, up from $1.18 billion a year earlier and exceeding the FactSet consensus estimate of $1.19 billion.</p>\n\n<p>The animal health company has raised its full-year 2025 outlook, now projecting adjusted earnings per share between $0.85 and $0.91, up from the previous forecast of $0.80 to $0.86. Revenue guidance for 2025 has also been increased to a range of $4.57 billion to $4.62 billion, compared to the earlier projection of $4.51 billion to $4.58 billion. This optimistic outlook, coupled with the strong Q2 performance, has fueled investor enthusiasm, driving the significant pre-market rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Elanco Animal Health Soars 9.25% Pre-Market on Strong Q2 Results and Raised 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Elanco Animal Health Soars 9.25% Pre-Market on Strong Q2 Results and Raised 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-07 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Elanco Animal Health Inc (ELAN) surged 9.25% in pre-market trading on Thursday following the release of the company's impressive second-quarter results and an upward revision of its full-year 2025 guidance.</p>\n\n<p>Elanco reported Q2 adjusted earnings of $0.26 per share, surpassing analysts' expectations of $0.20. While this represents a decrease from $0.30 in the same period last year, it demonstrates the company's resilience in a challenging market. Revenue for the quarter ended June 30 reached $1.24 billion, up from $1.18 billion a year earlier and exceeding the FactSet consensus estimate of $1.19 billion.</p>\n\n<p>The animal health company has raised its full-year 2025 outlook, now projecting adjusted earnings per share between $0.85 and $0.91, up from the previous forecast of $0.80 to $0.86. Revenue guidance for 2025 has also been increased to a range of $4.57 billion to $4.62 billion, compared to the earlier projection of $4.51 billion to $4.58 billion. This optimistic outlook, coupled with the strong Q2 performance, has fueled investor enthusiasm, driving the significant pre-market rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELAN","symbol_name":"Elanco Animal Health Inc","start_time":0,"source_url":"","article_id":"1135454044","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135454044","pubTimestamp":1754566869,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Elanco Animal Health Inc (ELAN) surged 9.25% in pre-market trading on Thursday following the release of the company's impressive second-quarter results and an upward revision of its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELAN":"Elanco Animal Health Inc"},"translate_title":"个股追踪|Elanco Animal Health盘前飙升9.25%，Q2业绩强劲，2025年展望上调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":1},"content_text":"Shares of Elanco Animal Health Inc (ELAN) surged 9.25% in pre-market trading on Thursday following the release of the company's impressive second-quarter results and an upward revision of its full-year 2025 guidance.\nElanco reported Q2 adjusted earnings of $0.26 per share, surpassing analysts' expectations of $0.20. While this represents a decrease from $0.30 in the same period last year, it demonstrates the company's resilience in a challenging market. Revenue for the quarter ended June 30 reached $1.24 billion, up from $1.18 billion a year earlier and exceeding the FactSet consensus estimate of $1.19 billion.\nThe animal health company has raised its full-year 2025 outlook, now projecting adjusted earnings per share between $0.85 and $0.91, up from the previous forecast of $0.80 to $0.86. Revenue guidance for 2025 has also been increased to a range of $4.57 billion to $4.62 billion, compared to the earlier projection of $4.51 billion to $4.58 billion. This optimistic outlook, coupled with the strong Q2 performance, has fueled investor enthusiasm, driving the significant pre-market rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}